Megestrol Acetate NDC 71335-2181

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2181Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2181Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-2181-1	71335218101	30 TABLET in 1 BOTTLE (71335-2181-1)Marketed from Oct 25, 2022
71335-2181-2	71335218102	100 TABLET in 1 BOTTLE (71335-2181-2)Marketed from Oct 25, 2022
71335-2181-3	71335218103	15 TABLET in 1 BOTTLE (71335-2181-3)Marketed from Oct 25, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Megestrol Acetate
Generic name (nonproprietary): megestrol acetate
Active ingredients: Megestrol acetate — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072423
Marketing start: Apr 4, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Progesterone Congeners (Chemical structure)
Identifiers: Product ID 71335-2181_c46a0f6c-4c7e-4278-81c7-4439cdbaec1fSPL ID c46a0f6c-4c7e-4278-81c7-4439cdbaec1fSPL set ID dd6617df-0876-4fc5-8435-b53d29ccc1aeRxCUI 860221UNII TJ2M0FR8ES
Pharmacologic class: Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335218101 followed by a unit qualifier and the quantity

Package 71335-2181-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 31, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Megestrol acetate tablets are indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (ie, recurrent, inoperable, or metastatic disease). It should not be used in lieu of currently accepted procedures such as surgery, radiation, or chemotherapy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072423

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072423
Product	Strength	Form · route	Labeler	Product NDC
Megestrol Acetate	Megestrol acetate 40 mg/1	TabletOral	Strides Pharma Science Limited	64380-159
Megestrol Acetate	Megestrol acetate 40 mg/1	TabletOral	Major Pharmaceuticals	0904-7236